BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23529605)

  • 1. [Safety of blood and blood products in the face of recent reports on the transmissibility of Alzheimer's disease in an animal experiment. Explanation to comment].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):585-9. PubMed ID: 23529605
    [No Abstract]   [Full Text] [Related]  

  • 2. [Safety of blood and blood products in the face of recent reports on the transmissibility of Alzheimer's disease in an animal experiment].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):584. PubMed ID: 23529604
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood transfusion safety].
    Koistinen J
    Duodecim; 2004; 120(7):902-4. PubMed ID: 15154312
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quality assurance management system for therapy with blood and blood products].
    Diekamp U
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):664-5. PubMed ID: 9825053
    [No Abstract]   [Full Text] [Related]  

  • 5. Neonatal transfusions.
    New HV; Stanworth SJ; Engelfriet CP; Reesink HW; McQuilten ZK; Savoia HF; Wood EM; Olyntho S; Trigo F; Wendel S; Lin Y; Hume H; Petäjä J; Krusius T; Villa S; Ghirardello S; von Lindern J; Brand A; Hendrickson JE; Josephson CD; Strauss RG; Luban NL; Paul W
    Vox Sang; 2009 Jan; 96(1):62-85. PubMed ID: 19121200
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recommendations for rationally-based hemotherapy].
    Welte M; Hachenberg T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):184-5. PubMed ID: 19266419
    [No Abstract]   [Full Text] [Related]  

  • 7. British Blood Transfusion Society. Blood Component Special Interest Group Symposium. Towards 'purer and safer' blood components and blood products. London, United Kingdom, 5 May 1994. Abstracts.
    Clin Lab Haematol; 1994 Dec; 16(4):379-406. PubMed ID: 7736717
    [No Abstract]   [Full Text] [Related]  

  • 8. When, why and how to order blood?
    Steenssens L
    Acta Anaesthesiol Belg; 2003; 54(4):313-4. PubMed ID: 14719351
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacterial contamination of blood products.
    Palavecino E; Jacobs M; Yomtovian R
    Curr Hematol Rep; 2004 Nov; 3(6):450-5. PubMed ID: 15496280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transfusions of blood and blood products and virus infections].
    Wróblewska M; Piotrowska E; ĺuczak M
    Postepy Hig Med Dosw; 2002; 56(2):221-40. PubMed ID: 12107964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety aspects of blood transfusion and European legislation.
    Koistinen JL
    Hematol J; 2004; 5 Suppl 3():S83-6. PubMed ID: 15190284
    [No Abstract]   [Full Text] [Related]  

  • 12. [New formulations in the guidelines and their importance for anesthesiologists].
    Götz E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):666-9. PubMed ID: 9825054
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood - surely but safely!].
    Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):905-6. PubMed ID: 22842882
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfusion in critically ill children: indications, risks, and challenges.
    Parker RI
    Crit Care Med; 2014 Mar; 42(3):675-90. PubMed ID: 24534955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transfusion and allergy].
    Mertes PM; Boudjedir K
    Transfus Clin Biol; 2013 May; 20(2):239-42. PubMed ID: 23587619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal.
    Flan B; Arrabal S
    Transfus Clin Biol; 2007 May; 14(1):51-62. PubMed ID: 17540602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patient information and follow-up of transfusions: "a checked report"?].
    Jullian H; Fuentes AM; Colavolpe JC; Gentille S
    Ann Fr Anesth Reanim; 1999 Apr; 18(4):fi60-3. PubMed ID: 10365217
    [No Abstract]   [Full Text] [Related]  

  • 18. Present status of blood component labeling. Specific proposals that meet current needs and provide for the future. International Society of Blood Transfusion Working Party on Automation and Data Processing.
    Steane EA
    Vox Sang; 1994; 67 Suppl 3():117-9. PubMed ID: 7975472
    [No Abstract]   [Full Text] [Related]  

  • 19. [Can virus safety of blood products be assured?].
    Krusius T
    Duodecim; 1994; 110(13):1227-30. PubMed ID: 7497931
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy with cellular blood components].
    Eichler H; Klüter H
    Internist (Berl); 2001 May; 42(5):760-8. PubMed ID: 11400584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.